A new systematic analysis uses network mapping to reveal novel disease associations and genetic pathways in autoimmune polyglandular syndrome (APS) . This approach is guiding both risk stratification and the identification of novel therapeutic targets to revolutionize the management of APS and related autoimmune endocrinopathies. To read more Click Here ##Reference## Pham-Dobor G, Kaltenecker P, Temesfoi V, et al. Systematic Analysis and Network Mapping of Disease Associations in Autoimmune Polyglandular Syndrome.
J Clin Endocrinol Metab. 2025;110(6):1716-1728.## How can network mapping most benefit APS research? a) Revealing overlapping molecular pathways b) Limiting cohort sizes c) Narrowing diagnostic focus d) Excluding rare phenotypes
